Serum testosterone may be associated with calcium oxalate urolithogenesis

Journal of Endourology

Volumn 24, Issue 7, 2010, Pages 1183-1187

  Watson, Justin M ^a   Shrewsberry, Adam B ^a   Taghechian, Shaya ^a   Goodman, Michael ^b   Pattaras, John G ^a   Ritenour, Chad W M ^a   Ogan, Kenneth ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ADULT; AGE; ANIMAL MODEL; ARTICLE; BODY MASS; CALCIUM OXALATE STONE; CONTROLLED STUDY; DEMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANK SUM TEST; RISK FACTOR; STONE FORMATION; TESTOSTERONE BLOOD LEVEL; UROLITHIASIS;

ADULT; AGED; CALCIUM OXALATE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TESTOSTERONE; UROLITHIASIS; YOUNG ADULT;

EID: 77954904762     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2010.0113     Document Type: Article

References (37)

1. Pak CY. Kidney stones. Lancet 1998;351:1797-1801.
2. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-1823.
3. Trinchieri A. Epidemiological trends in urolithiasis: Impact on our health care systems. Urol Res 2006;34:151-156.
4. Trinchieri A, Ostini F, Nespoli R, et al. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 1999;162:27-30.
5. Sutherland JW, Parks JH, Coe FL. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 1985;11:267-269.
6. Robertson WG, Peacock M, Heyburn PJ, Hanes FA. Epide-miological risk factors in calcium stone disease. Scand J Urol Nephrol 1980;53(suppl):15-30.
7. Soucie JM, Thun MJ, Coates RJ, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int 1994;46:893-899.
8. Fetter TR, Zimskind PD, Graham RH, ZBrodie DE. Statistical analysis of patients with ureteral calculi. JAMA 1963;186: 21-23.
9. Westbury EJ. Some observations on the quantitative analysis of over 1000 urinary calculi. Br J Urol 1974;46:215-227.
10. Lee YH, Huang WC, Tsai JY, et al. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 2002;68:172-177.
11. Kohri K, Kodama M, Ishikawa Y, et al. Relationship between metabolic acidosis and calcium phosphate urinary stone formation in women. Int Urol Nephrol 1991;23:307-316.
12. Marshall V, White RH, De Saintonage MC, et al. The natural history of renal and ureteral calculi. Br J Urol 1975;47: 117-124.
13. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: A 25-year study in Rochester, Minnesota. Kidney Int 1979;16:624-631
14. Soucie JM, Thun MJ, Coates RJ, et al. Demographic and geographic variability of kidney stones in the United States. Kidney Int 1994;46:893-899.
15. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-876.
16. Lee YH, Huang WC, Chiang H, et al. Determinant role of testosterone in the pathogenesis of urolithiasis in rats. J Urol 1992;147:1134-1138.
17. Lee YH, Huang WC, Huang JK, Chang LS. Testosterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats. J Urol 1996;156: 502-505.
18. Grant RP, Cameron C, Mackenzie-McMurter S. Generic serial and parallel on-line direct-injection using turbulent flow liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2002;16:1785-1792.
19. Sinha-Hikim I, Arver S, Beall G, et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 1998;83:1312-1318.
20. Finlayson B. Symposium on renal lithiasis. Renal lithiasis in review. Urol Clin North Am 1974;1:181-212.
21. Hodgkinson A. Citric acid excretion in normal adults and in patients with renal calculus. Clin Sci 1962;23:203-212.
22. Iguchi M, Kataoka K, Kohri K, et al. [Investigations of the causes of urolithiasis. 2. The influence of menstrual cycle on the excretion of citric acid and electrolytes.] (Jap) JNippon Hinyokika Gakkai Zasshi 1981;72:856-864.
23. Tiselius TG. Urinary excretion of citrate in normal subjects and in patients with urolithiasis. In: Urolithiasis: Clinical and Basic Research. New York: Plenum Press,1985 pp 39-44.
24. Richardson KE. Effect of testosterone on the glycolic acid oxidase levels in male and female rat liver. Endocrinology 1964;74:128-132.
25. Sharma V, Murthy MS, Thind SK, Nath R. Effect of sex hormone on oxalate synthesizing enzymes in weanling rats. Biochem Int 1981;3:507-515.
26. Xie Y, Sakatsume M, Nishi S, et al. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001;60:1645-1657.
27. Kohri K, Nomura S, Kitamura Y, et al. Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 1993;268:15180-15184.
28. Wesson JA, Johnson RJ, Mazzali M, et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol 2003;14:139-147.
29. Chang L, Feng T, Li J, et al. Regulation of osteopontin expression in a rat model of urolithiasis. Chin Med J 2001;114: 829-832.
30. Gao B, Yasui T, Okada A, et al. A polymorphism of the osteopontin gene is related to urinary calcium stones. J Urol 2005;174:1472-1476.
31. Yagisawa T, Ito F, Osaka Y, et al. The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis. J Urol 2001;166: 1078-1082.
32. Van Aswegen CH, Hurter P, van der Merwe CA, du Plessis DJ. The relationship between total urinary testosterone and renal calculi. Urol Res 1989;17:181-183.
33. Tiselius HG, Varenhorst E, Carlstrom K, Larsson L. Urinary oxalate excretion during anti-androgenic therapy. Invest Urol 1980;18:110-111.
34. Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ 2006;174:1407-1409.
35. Moe OW. Kidney stones: Pathophysiology and medical management. Lancet 2006;367:333-344.
36. Fan J, Glass MA, Chandhoke PS. Effect of castration and finasteride on urinary oxalate excretion in male rats. Urol Res 1998;26:71-75.
37. Mente A, Honey RJ, McLaughlin JR, et al. Ethnic differences in relative risk of idiopathic calcium nephrolithiasis in North America. J Urol 2007;178:1992-1997.